13F

Stock

Supernus Pharmaceuticals, Inc.

SUPN · held by 10 managers

Reported value

$89.9M

Holders

10

+0 new · −0 exited

Holders’ est. mark

$2.55M

Price effect on 3 books still in the name

Largest holder

$40.3M

BANK OF AMERICA CORP /DE/

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BANK OF AMERICA CORP /DE/842.9K$40.3MHeld
MORGAN STANLEY755.3K$36.1MHeld
BARCLAYS PLC231.2K$11M$2.29MAdded$6.61M
TUDOR INVESTMENT CORP ET AL30K$1.43MHeld
Henshaw Capital LLC15.4K$737.4K$251KAdded$73.8K
Persistent Asset Partners Ltd5.16K$246.5KHeld
IFP Advisors, Inc107$5.11KHeld
Allworth Financial LP89$4.25KHeld
Essential Partners LLC86$4.11K$992Added$2.19K
KBC Group NV1.77K$85Held

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.